Saudi-Irish study highlights major differences in MRI practice
August 18, 2017 -- An investigation of quality management for abdominal and pelvic MRI scans in Saudi Arabia and the Republic of Ireland has shown that staffing issues, variable adherence to local rules and procedures, and lack of policies governing work practices contribute to major fluctuations in clinical practice.  Discuss
New controversy emerges over gadolinium contrast agents
August 16, 2017 -- New guidelines on nephrogenic systemic fibrosis have prompted a strong reaction from radiologists and caused the author to consider revising his recommendations in a bid to restore the peace. He must take full account of a recent ruling on gadolinium-based contrast agents, Dr. Henrik Thomsen said.  Discuss
ISMRM offers guidelines for gadolinium MRI contrast
August 14, 2017 -- Taking what's described as a "wait and see approach," the International Society for Magnetic Resonance in Medicine (ISMRM) has published guidelines on the use of gadolinium-based MRI contrast agents in both clinical and research settings in an article published in the July issue of Lancet Neurology.  Discuss
How to tackle acute groin pain in top footballers
August 9, 2017 -- Football's World Cup is 10 months away, but already the medical community in Russia is starting to warm up for the event. Researchers have unveiled the findings of a significant study of groin injuries in professional football players from Russian Premier League side FC Locomotiv Moscow.  Discuss
EMA confirms clampdown on linear gadolinium agents
July 21, 2017 -- It's official: After months of intense lobbying and wrangling, the use of some linear gadolinium contrast agents in MRI will be restricted, and others are to be pulled from the market, following confirmation on Friday that the European Medicines Agency (EMA) has approved recommendations made on 7 July by the Pharmacovigilance Risk Assessment Committee.  Discuss
MRI provider calls for urgent action on patient safety
July 20, 2017 -- More sharing of safety events, as well as better data on contrast reactions and wider incidents, is essential if the MRI community is to learn from one another and establish good practices to help mitigate flaws in processes and human fallibility, a large study has found.  Discuss
Clinical success of 7T MRI requires only 'imagination'
July 19, 2017 -- Most 7-tesla MRI scans have been devoted to the brain and neuroscience, but researchers in Berlin are focusing on the clinical potential of ultrahigh-field MR for cardiac applications. They're convinced the time is now for the game-changing technology.  Discuss
DWI-MRI shows vision changes could predict Parkinson's
July 14, 2017 -- With the help of diffusion-weighted MR imaging (DWI-MRI), researchers in Italy have uncovered changes in the visual systems of patients newly diagnosed with Parkinson's disease, according to a study published online 11 July in Radiology.  Discuss
Gadolinium: PRAC modifies advice on contrast agents
July 10, 2017 -- After taking a long, hard, second look at the safety data of gadolinium-based MRI contrast agents, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency is backing off slightly from its prior recommendation that several gadolinium-based agents be pulled from the market.  Discuss
Human protein-based nanoprobes for MRI
July 7, 2017 -- An international team of researchers is reporting on the first-ever human protein-based tumor-targeting MRI contrast agent. The biohybrid composite, which can also be easily cleared by the body, could be used to detect tumors in their early stages, thanks to its enhanced MRI contrast and shorter proton relaxation time.  Discuss